PMC:7558914 / 250-808
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
43 | 372-390 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
44 | 529-547 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
63 | 20-29 | Disease | denotes | Andalusia | |
64 | 62-70 | Disease | denotes | COVID-19 | MESH:C000657245 |
65 | 112-121 | Disease | denotes | Andalusia | |
66 | 464-483 | Disease | denotes | respiratory illness | MESH:D012140 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 464-483 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 38-122 | Sentence | denotes | We reviewed the current COVID-19 protocols of the 15 largest hospitals in Andalusia. |
T5 | 123-307 | Sentence | denotes | Antiviral treatment, empirical antibacterial agents, adjunctive therapies, anticoagulant treatment, supportive care, hospital organization, and discharge recommendations were analyzed. |
T6 | 308-371 | Sentence | denotes | All protocols included were the latest updates as of July 2020. |
T7 | 372-519 | Sentence | denotes | Hydroxychloroquine in monotherapy was the most frequent antiviral drug recommended for mild respiratory illness with clinical risk factors (33.3%). |